Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Willman

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Blood|September 15, 1995
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- casesC P Leith, I M Chen, K J Kopecky, et al.
Blood|May 1, 1997
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group studyC P Leith, K J Kopecky, J Godwin, et al.
American Journal of Clinical Pathology|June 1, 1992
A comparative analysis of cytoplasmic mu (C mu) expression in acute lymphoblastic leukemia by molecular and immunologic techniques. Identification of leukemia cases expressing C mu mRNA transcripts in the absence of detectable C mu proteinsJ V Little, K Foucar, M H Duncan, et al.
Blood|August 1, 1995
Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemiaB Mehrotra, T I George, K Kavanau, et al.
Science (New York, N.Y.)|February 12, 1993
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasiaC L Willman, C E Sever, M G Pallavicini, et al.
Cancer Genetics and Cytogenetics|November 3, 1998
Trisomy 6 as a primary karyotypic aberration in hematologic disordersA N Mohamed, M L Varterasian, S M Dobin, et al.
Blood|June 15, 1995
Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemiaS A Shurtleff, S Meyers, S W Hiebert, et al.
Blood|July 10, 1998
Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion proteinD E Hogge, C L Willman, R J Kreitman, et al.
Genes, Chromosomes & Cancer|June 1, 1996
Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cellsP P Liu, C Wijmenga, A Hajra, et al.
Leukemia|January 27, 2006
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressureR E Gallagher, E L Schachter-Tokarz, D-C Zhou, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Blood|September 15, 1995
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- casesC P Leith, I M Chen, K J Kopecky, et al.
Blood|May 1, 1997
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group studyC P Leith, K J Kopecky, J Godwin, et al.
American Journal of Clinical Pathology|June 1, 1992
A comparative analysis of cytoplasmic mu (C mu) expression in acute lymphoblastic leukemia by molecular and immunologic techniques. Identification of leukemia cases expressing C mu mRNA transcripts in the absence of detectable C mu proteinsJ V Little, K Foucar, M H Duncan, et al.
Blood|August 1, 1995
Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemiaB Mehrotra, T I George, K Kavanau, et al.
Science (New York, N.Y.)|February 12, 1993
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasiaC L Willman, C E Sever, M G Pallavicini, et al.
Cancer Genetics and Cytogenetics|November 3, 1998
Trisomy 6 as a primary karyotypic aberration in hematologic disordersA N Mohamed, M L Varterasian, S M Dobin, et al.
Blood|June 15, 1995
Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemiaS A Shurtleff, S Meyers, S W Hiebert, et al.
Blood|July 10, 1998
Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion proteinD E Hogge, C L Willman, R J Kreitman, et al.
Genes, Chromosomes & Cancer|June 1, 1996
Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cellsP P Liu, C Wijmenga, A Hajra, et al.
Leukemia|January 27, 2006
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressureR E Gallagher, E L Schachter-Tokarz, D-C Zhou, et al.
Pageof 9